Big Money Sentiment decreased to 1.08 in Q4 2018. It has change of 0.68, from 2018Q3’s 1.76. The ratio turned negative due to SPPI positioning: 19 sold and 46 reduced. 19 funds amassed stakes and 51 increased stakes. Investors holded 85.20 million in 2018Q3 but now own 82.09 million shares or 3.65% less. 61,881 are owned by Manufacturers Life Insurance Company The. Commercial Bank Of America Corporation De has 185,636 shs for 0% of their capital. Exane Derivatives reported 3,026 shs. Barclays Public Limited Company stated it has 0% of its capital in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). State Street reported 5.86 million shs or 0% of all its holdings. 433,366 are held by Panagora Asset Mgmt. Pillar Pacific Mgmt Limited Liability holds 0.02% or 19,650 shs. Thrivent For Lutherans has 71,594 shs for 0% of their capital. Pnc Fincl Svcs Group owns 6,874 shs for 0% of their capital. Proshare Advsrs Ltd Liability Com reported 49,700 shs. Invesco owns 1.09 million shs for 0% of their capital. Legal General Public Limited Co, United Kingdom-based fund reported 255,744 shs. Sector Pension Invest Board holds 86,700 shs. Commonwealth Of Pennsylvania Pub School Empls Retrmt invested in 34,827 shs. 101,400 were accumulated by State Common Retirement Fund.

SPPI had 12 selling transactions and 0 insider buys since October 9, 2018. This’s net activity of $1.54 million. Another trade for 7,250 shs valued at $94,758 was sold by MAIDA ANTHONY E III. On Wednesday, January 16 the insider Turgeon Joseph W. sold $53,135. $109,578 worth of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was sold by Riga Thomas J. Another trade for 2,496 shs valued at $27,541 was sold by McGahan Keith M. Vyas Dolatrai had sold 6,010 shs worth $63,826 on Tuesday, January 22. Gagnon Gilles sold $153,349 worth of stock.

Consonance Capital Management Lp’s stake in Spectrum Pharmaceuticals Inc (SPPI) is decreased by 49.07% based on its latest 2018Q4 regulatory filing with the SEC. The company’s stock declined 21.14% while stock markets rallied as Consonance Capital Management Lp sold 2.86M shares. The health care company announced $25.98M value for the 2018Q4. Now the hedge fund is holding 2.97M shares, compared to the 5.83M from the previous quarter. $1.21B is the market cap of Spectrum Pharmaceuticals Inc. SPPI hit $11.06 during the last trading session after $0.47 change.Spectrum Pharmaceuticals, Inc. has volume of 496,027 shares. Since April 3, 2018 SPPI has declined 47.79% and is downtrending. SPPI underperformed the S&P500 by 52.16%.

A portfolio of $513.80 million and $1.36B is managed by Consonance Capital Management Lp. As it’s reported in Securities and Exchange form the stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) is increased by 215,000 shares to 4.66 million shares. They are valued at $121.73 million in 2018Q4. Consonance Capital Management Lp has risen its stake in United Therapeutics Corp Del (NASDAQ:UTHR) and also increased its holding in Corcept Therapeutics Inc (NASDAQ:CORT) by 1.17M shares in the quarter, for a total of 6.21M shares.

Earnings report for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is expected on May, 2., Zacks reports. Last year’s earnings per share was $-0.19, while now analysts expect change of 10.53 % down from current $-0.21 earnings per share. Wall Street now forecasts -38.24 % EPS growth despite Spectrum Pharmaceuticals, Inc. previous quarter’s EPS of $-0.34.

For more Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) news posted briefly go to: Benzinga.com, Globenewswire.com, Seekingalpha.com, Seekingalpha.com or Benzinga.com. The titles are as follows: “51 Stocks Moving In Friday’s Mid-Day Session – Benzinga” posted on March 15, 2019, “Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim’s Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” on March 25, 2019, “Spectrum Pharmaceuticals (SPPI) To Presemt At Oppenheimer 29th Annual Healthcare Conference – Slideshow – Seeking Alpha” with a publish date: March 21, 2019, “Spectrum Suffers BLA Setback, But Based On Deadline, It Was For The Better – Seeking Alpha” and the last “32 Stocks Moving In Friday’s Pre-Market Session – Benzinga” with publication date: March 15, 2019.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Ratings Coverage

Total analysts of 4 have positions in Spectrum Pharmaceuticals (NASDAQ:SPPI) as follows: 4 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since November 12, 2018 according to StockzIntelligence Inc Spectrum Pharmaceuticals has 7 analyst reports. In Friday, March 1 report H.C. Wainwright maintained it with “Buy” rating and $42 target. On Friday, March 15 the stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has “Buy” rating given by Cantor Fitzgerald. The stock rating was maintained by H.C. Wainwright with “Buy” on Friday, March 15. On Friday, March 15 the firm has “Buy” rating by Jefferies given. On Monday, November 12 the rating was maintained by FBR Capital with “Buy”. On Thursday, February 28 the stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) earned “Buy” rating by Cantor Fitzgerald.